- Home
- CSGP vs EW Comparison
CSGP vs EW Comparison
Compare CSGP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGP
- EW
- Stock Information
- Founded
- CSGP 1987
- EW 1958
- Country
- CSGP United States
- EW United States
- Employees
- CSGP N/A
- EW N/A
- Industry
- CSGP Business Services
- EW Industrial Specialties
- Sector
- CSGP Consumer Discretionary
- EW Health Care
- Exchange
- CSGP Nasdaq
- EW Nasdaq
- Market Cap
- CSGP 40.5B
- EW 44.8B
- IPO Year
- CSGP 1998
- EW 2000
- Fundamental
- Price
- CSGP $94.38
- EW $79.32
- Analyst Decision
- CSGP Buy
- EW Buy
- Analyst Count
- CSGP 12
- EW 20
- Target Price
- CSGP $94.00
- EW $85.00
- AVG Volume (30 Days)
- CSGP 3.0M
- EW 5.1M
- Earning Date
- CSGP 07-22-2025
- EW 07-24-2025
- Dividend Yield
- CSGP N/A
- EW N/A
- EPS Growth
- CSGP N/A
- EW 188.87
- EPS
- CSGP 0.25
- EW 7.02
- Revenue
- CSGP $2,915,500,000.00
- EW $5,685,100,000.00
- Revenue This Year
- CSGP $17.24
- EW $12.97
- Revenue Next Year
- CSGP $12.81
- EW $9.65
- P/E Ratio
- CSGP $384.62
- EW $33.19
- Revenue Growth
- CSGP 12.18
- EW 9.49
- 52 Week Low
- CSGP $68.26
- EW $59.41
- 52 Week High
- CSGP $97.15
- EW $83.00
- Technical
- Relative Strength Index (RSI)
- CSGP 77.98
- EW 56.40
- Support Level
- CSGP $84.26
- EW $75.39
- Resistance Level
- CSGP $97.15
- EW $81.88
- Average True Range (ATR)
- CSGP 1.83
- EW 1.78
- MACD
- CSGP 0.86
- EW 0.27
- Stochastic Oscillator
- CSGP 85.78
- EW 52.14
About CSGP CoStar Group Inc.
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.